Liaoning Cheng Da Co., Ltd. (SHA:600739)

China · Delayed Price · Currency is CNY

10.09

-0.15 (-1.46%)

Jun 18, 2026, 3:00 PM CST

-7.09% (1Y)

Market Cap	15.36B -5.3%
Revenue (ttm)	9.43B -12.4%
Net Income	940.13M +100.4%
EPS	0.62 +100.4%
Shares Out	1.52B
PE Ratio	16.34
Forward PE	n/a
Dividend	0.15 (1.46%)
Ex-Dividend Date	Jul 30, 2025

Volume	9,229,977
Open	10.25
Previous Close	10.24
Day's Range	10.03 - 10.25
52-Week Range	9.84 - 13.58
Beta	0.71
Analysts	Buy
Price Target	20.08 (+99.01%)
Earnings Date	Aug 31, 2026

About Liaoning Cheng Da

Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; rabies vaccines for human use and inactivated Japanese encephalitis vacc... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1991

Employees 2,740

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600739

Full Company Profile

Financial Performance

In 2025, Liaoning Cheng Da's revenue was 9.90 billion, a decrease of -8.06% compared to the previous year's 10.77 billion. Earnings were 736.55 million, an increase of 251.48%.

Financial Statements